1 of 24

Dr Shyamkumar Sriram

2 of 24

What are Sustainable Development Goals?

The Sustainable Development Goals (SDGs), also known as the Global Goals, were adopted by the United Nations in 2015 as a universal call to action to end poverty, protect the planet, and ensure that by 2030 all people enjoy peace and prosperity

3 of 24

SDGs

Total 17 Goals

  • Goal 1 – No Poverty
  • Goal 2 – Zero Hunger
  • Goal 3 – Good Health and Well-being
  • Goal 6 – Clean water and sanitation
  • Goal 7 – Affordable and clean energy
  • Goal 8 – Decent work and Economic Growth
  • Goal 10 – Reducing Inequalities
  • Goal 11 – Sustainable Cities and Communities
  • Goal 17 – Partnership for the Goals

4 of 24

Goal 3: Good Health and Well-being

Ensure healthy lives and promote well-being for all at all ages

The UN has defined 13 Targets and 28 Indicators for SDG 3

5 of 24

Targets for SDGs

3.1 By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births.

3.2 By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-5 mortality to at least as low as 25 per 1,000 live births.

3.3 By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases.

3.4 By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being.

3.5 Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol.

3.6 By 2020, halve the number of global deaths and injuries from road traffic accidents.

6 of 24

Sustainable Goals 3.3

SDG Target 3.3 | Communicable diseases:

By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases�

7 of 24

Tuberculosis

Targets for 2030

  • 90% reduction in the number of TB deaths and 80% reduction in the TB incidence rate (new cases per 100,000 population per year) compared with levels in 2015

  • The strategy also includes a 2020 milestone that no TB patients and their households face catastrophic costs as a result of TB disease

8 of 24

Universal Health Coverage

3 Dimensions of Universal Health Coverage (UHC)

- Population: who is covered?

- Services: which services are covered?

- Direct costs: proportion of the costs covered?

9 of 24

Health for All with Financial Protection

  • India is currently taking measures to provide universal health coverage (UHC) to its population

  • Providing financial protection is considered the backbone of UHC

  • The current policy debate is about “health for all with financial protection” from the concept of “health for all” which was more common in the last decade

  • Affordability and financial risk protection are key principles under the National Health Policy 2017 (NHP) of India

10 of 24

Catastrophic Health Costs�and Tuberculosis

TB disproportionately affects the socially and economically weaker sections of the society, the financial aspect of the disease cannot be ignored

TB is linked with poverty, so the End TB strategy emphasis reducing financial burden on those affected with the disease.

Many countries, aims to provide diagnosis and treatment of TB free of charge

11 of 24

Services Provided Free of Charge

India provides diagnosis and treatment of TB free of charge through its public health facilities.

Advanced ‘patient-centric care’ services provided:

  • Decentralised diagnostic and treatment services
  • Registration and follow-up of patients on web-based portal (NIKSHAY),
  • Provision of universal drug susceptibility testing for all TB patients
  • Provision of financial assistance for the nutrition of all notified TB patients

12 of 24

Defining Catastrophic Costs due to TB

Total Direct and Indirect costs that reach 20% of the TB patient’s household annual income

13 of 24

Are the catastrophic costs for Tuberculosis Treatment eliminated?

The 2020 milestone that no TB patients and their households face catastrophic costs as a result of TB disease

14 of 24

Tuberculosis Costs

  • Studies have shown that many patients and families affected by TB face high direct and indirect costs due to TB illness and use of health services, with many of those seeking healthcare services being at risk of impoverishment.

  • Several studies in India have highlighted the economic burden of TB, with a majority of the costs incurring during pre- diagnosis and intensive phases of treatment

15 of 24

CHE - Evidence from Global Studies

Globally, a systematic review and meta-analysis of CHE by TB patients (Ramy Mohamed Ghezt et al.)

5114 studies in the area were identified and 29 included in the final analysis

The pooled proportion of TB patients experiencing catastrophic costs was 43%

16 of 24

Main Predictors of Catastrophic Costs

  • Drug-sensitivity
  • Country
  • HIV co-infection

Predictors

Catastrophic Costs

Drug-sensitive

32%

Drug-resistant

81%

HIV-coinfection

81%

17 of 24

Passive case finding – 42%

Active case finding – 12%

Catastrophic costs varies by strategy of case finding:

18 of 24

Tamil Nadu Study

A community-based cross-sectional study done by Muniyandi et al. 2020

Pulmonary and extra-pulmonary TB patients registered in NTCP

The study showed catastrophic costs 31% (20% threshold)

19 of 24

Impoverishment due to Tuberculosis Treatment

  • A study done using the NSSO data studied the CHE and impoverishment due to Tuberculosis (Yadav et al. 2021)

  • Across hospitalisation and care, the percentage of the population falling below the PL and the average percentage deficit from the PL due to OOPE for TB fell in 2014 compared to 2004 but further increased in 2018.

  • Almost 50% of patients belonging to the middle-income category fell below the PL in 2018 due to hospitalisation OOPE.

  • Patients seeking private hospitals for TB treatment showed a considerably higher percentage of the population falling below the PL due to hospitalisation and care in all three rounds

20 of 24

Reducing Catastrophic Costs

Providing free medication is insufficient to prevent the catastrophic costs

MDR-TB requires a treatment of 24 months compared to 6 months for DS-TB – Leading to prolonged work absenteeism, more side effects, need for daily injections and more investigations

Households of TB should receive transport vouchers, reimbursement schemes, and food assistance to reduce or compensate for such catastrophic costs

21 of 24

Reducing Catastrophic Costs & Impoverishment

There is an increasing need for improving the Direct Benefit Transfer and Ayushman Bharat insurance scheme, for cash transfer to offset the expenditure impact of TB in the country.

Also, there is a need for better targeting especially among the illiterate, rural and poor sections of the society for these schemes.

There is also a need to consider the amount transferred under DBT as it would not be sufficient enough as compensation to manage the financial burden of TB of most patients.

There is a need for improved working and collaboration of private health facilities to provide TB care.

22 of 24

Malaria

The WHO Global technical strategy for malaria 2016-2030 – adopted by the World Health Assembly in May 2015 – provides a technical framework for all malaria-endemic countries.

The Strategy sets ambitious but achievable global targets, including:

  • reducing malaria case incidence by at least 90% by 2030;
  • reducing malaria mortality rates by at least 90% by 2030;
  • eliminating malaria in at least 35 countries by 2030;
  • preventing a resurgence of malaria in all countries that are malaria-free.

23 of 24

Malaria

The cost of implementing the GTS was estimated at about US$ 101.8 billion over 15 years.

Global investments in malaria control was US$ 2.5 billion in 2015.

By 2025, the annual requirement is estimated at US$ 7.7 billion, and by 2030, US$ 8.7 billion.

A further estimated US$ 673 million is also needed each year to fund malaria research and development.

GTS implementation will translate into US$ 4 trillion of additional economic output over the 2016–2030 timeframe. The global return on investment is estimated at 40:1.

24 of 24

THANKS!

QUESTIONS?